Potential inhibitor for 2019-novel coronaviruses in drug development
The coronavirus disease 2019 (COVID-19), which is first detected in Wuhan, China, is a virus identified as the cause of pneumonia. In the event of epidemic outbreak, a series of actions have been taken by the Chinese government to control the pandemic of the virus, and effective medical methods are...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Cancer Translational Medicine |
| Subjects: | |
| Online Access: | http://www.cancertm.com/article.asp?issn=2395-3977;year=2020;volume=6;issue=1;spage=17;epage=20;aulast=Xu |